srNopsis Thirty-four healthy blood donors, found to be persistent HBAg carriers, have been investigated by means of serial liver function tests, bromsulphthalein (BSP) retention, and liver biopsy. Thirty-one of the donors had histological abnormalities including one with cirrhosis, three with chronic aggressive hepatitis, and 11 with chronic persistent hepatitis. In 13 biopsies there were focal areas of necrosis in the liver parenchyma. Serial liver function tests revealed abnormalities in each ofthe donors with cirrhosis orwith chronic aggressive hepatitis, in seven of the 11 donors with chronic persistent hepatitis, and in seven of the 13 with focal parenchymal necrosis. The degree of BSP retention was greatest (>11 %) in the donors with chronic aggressive hepatitis. The severity of the histological changes was related neither to the titre of the antigen in the serum nor to the presence of autoantibodies.
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The association of the hepatitis B antigen (HBAg, Australia antigen, HAA) with serum hepatitis is now well established. It is also being increasingly implicated in chronic liver disease (Krohn, Finlayson, Jokelainen, Anderson, and Prince, 1970; Hadziyannis, Merikas, and Afroudakis, 1970; Dudley, Fox, and Sherlock, 1971) .
The routine screening of donor blood by blood transfusion serviceshas identifiedsubstantialnumbers of asymptomatic HBAg carriers (Kliman, Reid, Lilly, and Morrison, 1971; Wallace, Milne, and Barr, 1972) although the full implications of this carrier state remain to be determined. Several reports from other countries have recorded a varying incidence of liver abnormalities (Singleton, Fitch, Merrill, Kohler, and Rettberg, 1971; Bolin, Davis, and Liddelow, 1973) . This report records our findings in a group of healthy asymptomatic volunteer blood donors in the north west of England.
Patients and Methods Screening of donor blood for the presence of HBAg was begun in March 1970 using immunoelectroosmophoresis (Stratton, 1972 (Public Health Laboratory Service, Manchester) using similar methodology. The results of positive tests were reported to the family practitioners, with whose consent arrangements were subsequently made for these donors to be reviewed in the Liver Clinic at the University Hospital of South Manchester.
Thirty-four donors who had persistent antigenaemia were investigated for evidence of liver disease. In each donor an attempt was made by careful questioning to elicit a possible source of infection. The investigations performed included a serum bilirubin, alkaline phosphatase, aspartate and alanine aminotransferases (SGOT/SGPT), albumin and globulin levels, protein electrophoresis, and prothrombin time. These tests were performed at three monthly intervals over a period of one to two years. Using standard indirect immunofluorescence technique the sera were screened for smooth muscle antibody (Johnson, Holborow, and Glynn, 1965) , antinuclear factor (Beck, 1961) , and antimitochondrial antibody (Goudie, MacSween, and Goldberg, 1966 ! > * . . aggregations of lymphocytes and histiocytes in which only one or two liver cells had disappeared (fig 1) . In larger lesions there was considerable necrosis of the liver parenchyma, most of the parenchymal cells being replaced by lymphocytes and histiocytes (fig 2) . In some lesions the inflammatory cells infiltrated the adjacent normal tissue (fig 3) . Apparently incidental lesions were seen in three other donors. These were fatty change in two biopsies and multiple granulomata in one. Asymptomatic liver disease in hepatitis B antigen carriers Discussion All the donors in this survey were completely asymptomatic and in most instances physical examination was non-contributory. None had ever been jaundiced and in no instance was it possible to identify an illness which might have represented anicteric hepatitis. All the donors had been HBAg positive for a minimum of six months before liver biopsy and all have remained so for at least six months subsequently. All may, therefore, be regarded as established carriers.
The age and sex distributions of the donor sample investigated are comparable to those in other series of volunteer donors (Kliman, Reid, Lilly, and Morrison, 1971; Reinicke, Dybkjaer, Poulsen, Bank, Lylloff, and Nordenfelt, 1972; Wallace et al, 1972) . In nearly half of the donors it was not possible to elicit a history of exposure to the antigen. In one third of the donors there was a history of contact with hepatitis, and other possible sources included tattooing and mosquito bites, both of which have been recently incriminated as routes of infection with hepatitis B virus (Mowat, Albert-Recht, Brunt, and Walker, 1973; Prince, Metselaar, Kafuko, Mukwaya, Ling, and Overby, 1972) . Two of the donors were hospital employees and it has been suggested that hospital personnel may have an increased frequency of antigen carriage (Soulier, Courouce-Pauty, and Benamon-Djiane, 1969) . One of the important factors revealed by the present study is the high incidence of histological abnormalities in the biopsies and in particular the occurrence of cirrhosis and chronic aggressive hepatitis in asymptomatic HBAg carriers who were not users of narcotics. Chronic aggressive hepatitis has been reported in asymptomatic carriers in only two previous series (Singleton et al, 1971; Bolin et al, 1973) but both these studies included drug addicts and it has been suggested that such use of narcotics itself may be responsible for the production of chronic aggressive hepatitis (Cherubin, Rosenthal, Stenger, Prince, Baden, Strauss, and McGinn, 1972) . Chronic persistent hepatitis was present in 11 (32 %) of the biopsies. This incidence is in marked contrast to that reported by Reinicke et al (1972) who found only two instances (8 %) in a comparable study from Denmark. The lesions we have labelled focal parenchymal necrosis have not been described previously in biopsies from HBAg-positive blood donors. They are clearly much larger than the minor parenchymal lesions described by Ricci, De Bac, and Caramia (1972) and their significance may become apparent in later studies.
The explanation for the spectrum of histological changes encountered is at present obscure. Our investigations have failed to confirm the suggestion (Dudley et al, 1971 ) that there is a correlation between the severity of liver damage and the titre of the antigen in the serum. The low incidence of autoantibodies in this series (15%) is in contrast to Holborow's (1972) 
